DREADD
Designer receptors exclusively activated by designer drugs (DREADDs) are genetically engineered GPCRs that are activated by physiologically inert synthetic small molecules (designer drugs) but not their endogenous ligand. Read our DREADDs mini-review or for practical advice on using these ligands in the lab see Stability of Water-Soluble DREADD Ligands in Solution: A Technical Review and Clozapine N-Oxide (freebase) - a technical review on stability, solubility and use in the lab).
- Description:
mGlu5 negative allosteric modulator
Purity:>98%
-
Rebeccamycin (HB4052)
Description:Weak topoisomerase I inhibitor. Shows no activity against protein kninases.
Purity:>98%
-
Recombinant human Artemin protein (HB8222)
Description:Neurotrophic factor from the GDNF family ligands
- Description:
HEK expressed recombinant human BDNF protein
- Description:
His tag recombinant human BDNF protein
- Description:
CHO-expressed recombinant human beta-NGF protein
-
Recombinant human beta-NGF protein (HB9303)
Description:Neurotrophic factor related to BDNF, NT-3 and NT-4
-
Recombinant human CDNF protein (HB8544)
Description:Neurotrophin implicated in Parkinson’s disease research
- Description:
His tag active recombinant human BDNF protein
